NCT07105215 2025-11-26
A I/II Phase Clinical Study to Evaluate the Safety and Efficacy of RC278 in the Treatment of Solid Tumors
RemeGen Co., Ltd.
Phase 1/2 Recruiting
RemeGen Co., Ltd.
Tcelltech Inc.
BPGbio
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
RemeGen Co., Ltd.